特集／薬剤経済学研究に関する最近の話題
２． 臨床試験と薬剤経済学研究
2010 年 41 巻 6 号 p. 271-274
詳細
2010 年 41 巻 6 号 p. 271-274
The future of pharmacoeconomics in comparison with clinical research consists of collection of cost data, and the use of different outcomes measures from clinical trials. In pharmacoeconomic analysis using the data of the clinical development phase, the data that can be used for analysis have various restrictions. Pharmaceutical companies need to draw up a pharmacoeconomic research plan from the early stage of development. Moreover, creation of research guidelines is also needed based on clarification of the use of research results for health policy such as pricing.
